IBDEI0I7 ; ; 20-FEB-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 20, 2013
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,680,0)
 ;;=INFECTIONS^7^79
 ;;^UTILITY(U,$J,358.4,681,0)
 ;;=LOW VISION/BLINDNESS^11^79
 ;;^UTILITY(U,$J,358.4,682,0)
 ;;=MOST COMMON & POST OP^0^79
 ;;^UTILITY(U,$J,358.4,683,0)
 ;;=OTHER^12^79
 ;;^UTILITY(U,$J,358.4,684,0)
 ;;=NEW PATIENT^2^80
 ;;^UTILITY(U,$J,358.4,685,0)
 ;;=ESTABLISHED PATIENT^1^80
 ;;^UTILITY(U,$J,358.4,686,0)
 ;;=CONSULTATIONS^3^80
 ;;^UTILITY(U,$J,358.4,687,0)
 ;;=BIOPSY/DEBRIDEMENT^1^81
 ;;^UTILITY(U,$J,358.4,688,0)
 ;;=I&D/ASPIRATION^3^81
 ;;^UTILITY(U,$J,358.4,689,0)
 ;;=DESTRUCT-BENIGN/PREMALIG LESIONS^4^81
 ;;^UTILITY(U,$J,358.4,690,0)
 ;;=SCOPES^5^81
 ;;^UTILITY(U,$J,358.4,691,0)
 ;;=POST-OP COMPLICATIONS^16^82
 ;;^UTILITY(U,$J,358.4,692,0)
 ;;=GENERAL/SIGNS & SYMPTOMS^6^82
 ;;^UTILITY(U,$J,358.4,693,0)
 ;;=GYN/BREAST^8^82
 ;;^UTILITY(U,$J,358.4,694,0)
 ;;=MALE BREAST^10^82
 ;;^UTILITY(U,$J,358.4,695,0)
 ;;=BENIGN LESIONS OF SKIN^3^82
 ;;^UTILITY(U,$J,358.4,696,0)
 ;;=MALIGNANT LESIONS OF SKIN^11^82
 ;;^UTILITY(U,$J,358.4,697,0)
 ;;=MELANOMA^12^82
 ;;^UTILITY(U,$J,358.4,698,0)
 ;;=LACERATIONS^9^82
 ;;^UTILITY(U,$J,358.4,699,0)
 ;;=MERKEL CELL CANCER^13^82
 ;;^UTILITY(U,$J,358.4,700,0)
 ;;=AFTERCARE POST SURGERY^2^82
 ;;^UTILITY(U,$J,358.4,701,0)
 ;;=CARDIOVASCULAR^4^82
 ;;^UTILITY(U,$J,358.4,702,0)
 ;;=ENT^5^82
 ;;^UTILITY(U,$J,358.4,703,0)
 ;;=ABDOMINAL PAIN^1^82
 ;;^UTILITY(U,$J,358.4,704,0)
 ;;=GI^7^82
 ;;^UTILITY(U,$J,358.4,705,0)
 ;;=RESPIRATORY^17^82
 ;;^UTILITY(U,$J,358.4,706,0)
 ;;=ORTHOPEDIC^14^82
 ;;^UTILITY(U,$J,358.4,707,0)
 ;;=PLASTIC SURGERY^15^82
 ;;^UTILITY(U,$J,358.4,708,0)
 ;;=UROLOGY^18^82
 ;;^UTILITY(U,$J,358.4,709,0)
 ;;=ESOPHAGUS^2^83
 ;;^UTILITY(U,$J,358.4,710,0)
 ;;=STOMACH/DUODENUM^7^83
 ;;^UTILITY(U,$J,358.4,711,0)
 ;;=SMALL BOWEL^6^83
 ;;^UTILITY(U,$J,358.4,712,0)
 ;;=LARGE BOWEL/RECTUM^3^83
 ;;^UTILITY(U,$J,358.4,713,0)
 ;;=SYMPTOMS^1^83
 ;;^UTILITY(U,$J,358.4,714,0)
 ;;=LIVER^4^83
 ;;^UTILITY(U,$J,358.4,715,0)
 ;;=PANCREAS^5^83
 ;;^UTILITY(U,$J,358.4,716,0)
 ;;=ESOPHAGUS^1^84
 ;;^UTILITY(U,$J,358.4,717,0)
 ;;=SMALL INTESTINE ENDOSCOPY^2^84
 ;;^UTILITY(U,$J,358.4,718,0)
 ;;=SIGMOIDOSCOPY/PROCTOSIGMOIDOSCOPY^3^84
 ;;^UTILITY(U,$J,358.4,719,0)
 ;;=COLONOSCOPY^5^84
 ;;^UTILITY(U,$J,358.4,720,0)
 ;;=ERCP^6^84
 ;;^UTILITY(U,$J,358.4,721,0)
 ;;=G-TUBE^7^84
 ;;^UTILITY(U,$J,358.4,722,0)
 ;;=MISCELLANEOUS-PROCEDURES^8^84
 ;;^UTILITY(U,$J,358.4,723,0)
 ;;=IMMUNIZATIONS/INJECTIONS^9^84
 ;;^UTILITY(U,$J,358.4,724,0)
 ;;=NEW PATIENT^2^85
 ;;^UTILITY(U,$J,358.4,725,0)
 ;;=ESTABLISHED PATIENT^1^85
 ;;^UTILITY(U,$J,358.4,726,0)
 ;;=CONSULTATIONS^3^85
 ;;^UTILITY(U,$J,358.4,727,0)
 ;;=ORTHOTIC DEVICES^2^86
 ;;^UTILITY(U,$J,358.4,728,0)
 ;;=THERAPY EVALUATIONS^3^86
 ;;^UTILITY(U,$J,358.4,729,0)
 ;;=HOME THERAPY SERVICES^1^86
 ;;^UTILITY(U,$J,358.4,730,0)
 ;;=V CODES ^1^87
 ;;^UTILITY(U,$J,358.4,731,0)
 ;;=AMPUTATION STATUS^2^87
 ;;^UTILITY(U,$J,358.4,732,0)
 ;;=BRAIN DISORDERS^3^87
 ;;^UTILITY(U,$J,358.4,733,0)
 ;;=CARDIOPULMONARY^4^87
 ;;^UTILITY(U,$J,358.4,734,0)
 ;;=COMPLICATION DUE TO^5^87
 ;;^UTILITY(U,$J,358.4,735,0)
 ;;=FRACTURES-LATE EFFECTS^6^87
 ;;^UTILITY(U,$J,358.4,736,0)
 ;;=MENTAL DISORDERS^7^87
 ;;^UTILITY(U,$J,358.4,737,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^8^87
 ;;^UTILITY(U,$J,358.4,738,0)
 ;;=TERTIARY DX-TBI CODES^10^87
 ;;^UTILITY(U,$J,358.4,739,0)
 ;;=QUATERNARY DX-POLYTRAUMA/TBI V-CODE^9^87
 ;;^UTILITY(U,$J,358.4,740,0)
 ;;=PRIMARY DIAGNOSES^1^88
 ;;^UTILITY(U,$J,358.4,741,0)
 ;;=HOSPICE CARE SUPERVISION^1^89
 ;;^UTILITY(U,$J,358.4,742,0)
 ;;=TEAM CONFERENCES^2^89
 ;;^UTILITY(U,$J,358.4,743,0)
 ;;=INPATIENT CONSULTATIONS^1^90
 ;;^UTILITY(U,$J,358.4,744,0)
 ;;=INITIAL INPATIENT CARE^2^90
 ;;^UTILITY(U,$J,358.4,745,0)
 ;;=SUBSEQUENT INPATIENT CARE^3^90
 ;;^UTILITY(U,$J,358.4,746,0)
 ;;=CANCER & HEMATOLOGIC CONDITIONS^2^91
 ;;^UTILITY(U,$J,358.4,747,0)
 ;;=PALLIATIVE/HOSPICE ENCOUNTER^1^91
 ;;^UTILITY(U,$J,358.4,748,0)
 ;;=CNS CONDITIONS OTHER THAN CANCER^3^91
 ;;^UTILITY(U,$J,358.4,749,0)
 ;;=CARDIOPULMONARY COND OTHER THAN CANCER^4^91
 ;;^UTILITY(U,$J,358.4,750,0)
 ;;=GASTROINTESTINAL COND OTHER THAN CANCER^5^91
 ;;^UTILITY(U,$J,358.4,751,0)
 ;;=RENAL COND OTHER THAN CANCER^6^91
 ;;^UTILITY(U,$J,358.4,752,0)
 ;;=DERMATOLOGIC CONDITIONS^7^91
 ;;^UTILITY(U,$J,358.4,753,0)
 ;;=RHEUMATOLOGIC/VASCULITIC/THROMBOEMBOLIC^8^91
 ;;^UTILITY(U,$J,358.4,754,0)
 ;;=INFECTIOUS CONDITIONS & SIRS^9^91
 ;;^UTILITY(U,$J,358.4,755,0)
 ;;=HOSPICE CARE SUPERVISION^1^92
 ;;^UTILITY(U,$J,358.4,756,0)
 ;;=TEAM CONFERENCES^2^92
 ;;^UTILITY(U,$J,358.4,757,0)
 ;;=NEW PATIENT ^2^93
 ;;^UTILITY(U,$J,358.4,758,0)
 ;;=ESTABLISHED PATIENT ^1^93
 ;;^UTILITY(U,$J,358.4,759,0)
 ;;=CONSULTATIONS ^3^93
 ;;^UTILITY(U,$J,358.4,760,0)
 ;;=CANCER & HEMATOLOGIC CONDITIONS^2^94
 ;;^UTILITY(U,$J,358.4,761,0)
 ;;=PALLIATIVE/HOSPICE ENCOUNTER^1^94
 ;;^UTILITY(U,$J,358.4,762,0)
 ;;=CNS CONDITIONS OTHER THAN CANCER^3^94
 ;;^UTILITY(U,$J,358.4,763,0)
 ;;=CARDIOPULMONARY COND OTHER THAN CANCER^4^94
 ;;^UTILITY(U,$J,358.4,764,0)
 ;;=GASTROINTESTINAL COND OTHER THAN CANCER^5^94
 ;;^UTILITY(U,$J,358.4,765,0)
 ;;=RENAL COND OTHER THAN CANCER^6^94
 ;;^UTILITY(U,$J,358.4,766,0)
 ;;=DERMATOLOGIC CONDITIONS^7^94
 ;;^UTILITY(U,$J,358.4,767,0)
 ;;=RHEUMATOLOGIC/VASCULITIC/THROMBOEMBOLIC^8^94
 ;;^UTILITY(U,$J,358.4,768,0)
 ;;=INFECTIOUS CONDITIONS & SIRS^9^94
 ;;^UTILITY(U,$J,358.4,769,0)
 ;;=NEW PATIENT^2^95
 ;;^UTILITY(U,$J,358.4,770,0)
 ;;=ESTABLISHED PATIENT^1^95
 ;;^UTILITY(U,$J,358.4,771,0)
 ;;=CONSULTATIONS^3^95
 ;;^UTILITY(U,$J,358.4,772,0)
 ;;=PROCEDURES^1^96
 ;;^UTILITY(U,$J,358.4,773,0)
 ;;=CARDIOVASCULAR^2^97
 ;;^UTILITY(U,$J,358.4,774,0)
 ;;=DERMATOLOGY^3^97
 ;;^UTILITY(U,$J,358.4,775,0)
 ;;=GENERAL^1^97
 ;;^UTILITY(U,$J,358.4,776,0)
 ;;=EENT^4^97
 ;;^UTILITY(U,$J,358.4,777,0)
 ;;=ENDOCRINOLOGY^5^97
 ;;^UTILITY(U,$J,358.4,778,0)
 ;;=GI^6^97
 ;;^UTILITY(U,$J,358.4,779,0)
 ;;=HEMATOLOGY^7^97
 ;;^UTILITY(U,$J,358.4,780,0)
 ;;=HIV STATUS & RELATED DX^8^97
 ;;^UTILITY(U,$J,358.4,781,0)
 ;;=NEPHRO/GU^9^97
 ;;^UTILITY(U,$J,358.4,782,0)
 ;;=NEUROLOGY^10^97
 ;;^UTILITY(U,$J,358.4,783,0)
 ;;=PAIN^11^97
 ;;^UTILITY(U,$J,358.4,784,0)
 ;;=PYSCHIATRY/SUBSTANCE ABUSE^12^97
 ;;^UTILITY(U,$J,358.4,785,0)
 ;;=RHEUMATOLOGY^13^97
 ;;^UTILITY(U,$J,358.4,786,0)
 ;;=RESPIRATORY^14^97
 ;;^UTILITY(U,$J,358.4,787,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCE^.5^97
 ;;^UTILITY(U,$J,358.4,788,0)
 ;;=INITIAL OBSERVATION^1^98
 ;;^UTILITY(U,$J,358.4,789,0)
 ;;=INPT BEDSIDE VISIT-INITIAL CARE^3^98
 ;;^UTILITY(U,$J,358.4,790,0)
 ;;=INPT-CONSULTATIONS^5^98
 ;;^UTILITY(U,$J,358.4,791,0)
 ;;=OBSERVATION DISCHARGE^2^98
 ;;^UTILITY(U,$J,358.4,792,0)
 ;;=INPT BEDSIDE VISITS-DAILY VISITS^4^98
 ;;^UTILITY(U,$J,358.4,793,0)
 ;;=ADMIT & DISCHARGE SAME DAY^6^98
 ;;^UTILITY(U,$J,358.4,794,0)
 ;;=DISCHARGE DAY CODES^7^98
 ;;^UTILITY(U,$J,358.4,795,0)
 ;;=CARDIOVASCULAR^3^99
 ;;^UTILITY(U,$J,358.4,796,0)
 ;;=RESPIRATORY^13^99
 ;;^UTILITY(U,$J,358.4,797,0)
 ;;=MUSCULOSKELETAL^10^99
 ;;^UTILITY(U,$J,358.4,798,0)
 ;;=NEUROLOGIC^11^99
 ;;^UTILITY(U,$J,358.4,799,0)
 ;;=GASTROENTEROLOGY^5^99
 ;;^UTILITY(U,$J,358.4,800,0)
 ;;=GENITOURINARY^6^99
 ;;^UTILITY(U,$J,358.4,801,0)
 ;;=HEMATOLOGY/ONCOLOGY^7^99
 ;;^UTILITY(U,$J,358.4,802,0)
 ;;=INJURY/TRAUMA^8^99
 ;;^UTILITY(U,$J,358.4,803,0)
 ;;=SIGNS/SYMPTOMS^2^99
 ;;^UTILITY(U,$J,358.4,804,0)
 ;;=PAIN^12^99
 ;;^UTILITY(U,$J,358.4,805,0)
 ;;=COMPLICATIONS^4^99
 ;;^UTILITY(U,$J,358.4,806,0)
 ;;=MASS^9^99
 ;;^UTILITY(U,$J,358.4,807,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^1^99
 ;;^UTILITY(U,$J,358.4,808,0)
 ;;=SUBSEQUENT OBSERVATION^1^100
 ;;^UTILITY(U,$J,358.4,809,0)
 ;;=BLIND REHAB SERVICE CODES^1^101
 ;;^UTILITY(U,$J,358.4,810,0)
 ;;=REFRACTION^3^101
 ;;^UTILITY(U,$J,358.4,811,0)
 ;;=GLASSES/CONTACT LENSES^4^101
 ;;^UTILITY(U,$J,358.4,812,0)
 ;;=VISUAL FIELDS^5^101
 ;;^UTILITY(U,$J,358.4,813,0)
 ;;=PHOTOGRAPHY^6^101
 ;;^UTILITY(U,$J,358.4,814,0)
 ;;=LOW VISION^7^101
 ;;^UTILITY(U,$J,358.4,815,0)
 ;;=SPECIAL PROCEDURES^8^101
 ;;^UTILITY(U,$J,358.4,816,0)
 ;;=TEAM MEETINGS/COUNSELING^10^101
 ;;^UTILITY(U,$J,358.4,817,0)
 ;;=ESTABLISHED PATIENT^1^102
 ;;^UTILITY(U,$J,358.4,818,0)
 ;;=NEW PATIENT^2^102
 ;;^UTILITY(U,$J,358.4,819,0)
 ;;=VISION DDX (CODE BY BETTER EYE)^1^103
 ;;^UTILITY(U,$J,358.4,820,0)
 ;;=DIABETES^4^103
 ;;^UTILITY(U,$J,358.4,821,0)
 ;;=GLAUCOMA^4^103
 ;;^UTILITY(U,$J,358.4,822,0)
 ;;=VF HA EOM OTHER^5^103
 ;;^UTILITY(U,$J,358.4,823,0)
 ;;=LIDS AND LASHES^6^103
 ;;^UTILITY(U,$J,358.4,824,0)
 ;;=CONJUNCTIVA, CORNEA, AND SCLERA^7^103
 ;;^UTILITY(U,$J,358.4,825,0)
 ;;=PUPILS/IRIS^8^103
 ;;^UTILITY(U,$J,358.4,826,0)
 ;;=LENS AND VITREOUS^9^103
 ;;^UTILITY(U,$J,358.4,827,0)
 ;;=MACULA AND OPTIC NERVE^10^103
 ;;^UTILITY(U,$J,358.4,828,0)
 ;;=RETINA^11^103
 ;;^UTILITY(U,$J,358.4,829,0)
 ;;=GLOBE/ORBIT^12^103
 ;;^UTILITY(U,$J,358.4,830,0)
 ;;=V CODES^13^103
 ;;^UTILITY(U,$J,358.4,831,0)
 ;;=MFH-NON CLINICIAN VISIT CODES^2^104
 ;;^UTILITY(U,$J,358.4,832,0)
 ;;=NURSING PROCEDURES^3^104
 ;;^UTILITY(U,$J,358.4,833,0)
 ;;=SPLINTS^4^104
 ;;^UTILITY(U,$J,358.4,834,0)
 ;;=MFH-CLINICIAN VISIT CODES^1^104
 ;;^UTILITY(U,$J,358.4,835,0)
 ;;=CARDIOVASCULAR^2^105
 ;;^UTILITY(U,$J,358.4,836,0)
 ;;=ENDOCRINE/METABOLIC^4^105
 ;;^UTILITY(U,$J,358.4,837,0)
 ;;=PULMONARY^20^105
 ;;^UTILITY(U,$J,358.4,838,0)
 ;;=EENT^5^105
 ;;^UTILITY(U,$J,358.4,839,0)
 ;;=MUSCULOSKELETAL^10^105
 ;;^UTILITY(U,$J,358.4,840,0)
 ;;=NEURO^15^105
 ;;^UTILITY(U,$J,358.4,841,0)
 ;;=MENTAL HEALTH^13^105
 ;;^UTILITY(U,$J,358.4,842,0)
 ;;=GASTROENTEROLOGY^6^105
 ;;^UTILITY(U,$J,358.4,843,0)
 ;;=GU / RENAL^7^105
 ;;^UTILITY(U,$J,358.4,844,0)
 ;;=WOMEN'S HEALTH^28^105
 ;;^UTILITY(U,$J,358.4,845,0)
 ;;=HEMATOLOGY/ONCOLOGY^8^105
 ;;^UTILITY(U,$J,358.4,846,0)
 ;;=INFECTIOUS DISEASE^9^105
 ;;^UTILITY(U,$J,358.4,847,0)
 ;;=DERMATOLOGY^3^105
 ;;^UTILITY(U,$J,358.4,848,0)
 ;;=HISTORY OF ILLNESS^29^105
 ;;^UTILITY(U,$J,358.4,849,0)
 ;;=PREVENTIVE HEALTH/SCREENINGS^31^105
